Finance

Lists
GANX:NASDAQ
Gain Therapeutics Inc
$1.72
0.00%
(0.00) 1D
Sep 10, 3:45:53 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
$1.72
High
$1.74
Low
$1.69
Mkt. cap
74.63M
Avg. vol.
452.06K
Volume
423.67K
52-wk high
$4.34
52-wk low
$1.53
EPS
-$0.51
Beta
0.20
Shares outstanding
43.64M
No. of employees
21
Open
$1.72
High
$1.74
Low
$1.69
Mkt. cap
74.63M
Avg. vol.
452.06K
Volume
423.67K
52-wk high
$4.34
52-wk low
$1.53
EPS
-$0.51
Beta
0.20
Shares outstanding
43.64M
No. of employees
21
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorBiotechnology
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current $1.72
$8.00 (+365.12%)
Average
$7.20 (+318.60%)
Lowest
$5.00 (+190.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$8.00
+365.1%
08/31/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$8.00
+365.1%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$7.00
+307%
08/13/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$8.00
+365.1%
08/13/2026
Thomas Shrader
BTIG
Buy
Maintained
$5.00
+190.7%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
2.81M
2.32M
2.74M
2.12M
Cost of revenue
2.81M
2.32M
2.74M
2.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.98M
2.15M
2.61M
2.56M
Operating expense
1.98M
2.15M
2.61M
2.56M
Total operating expenses
4.79M
4.47M
5.35M
4.68M
Operating income
-4.79M
-4.47M
-5.35M
-4.68M
Other non operating income
-
-
-
-
EBT including unusual items
-4.74M
-4.47M
-5.43M
-4.57M
EBT excluding unusual items
-4.74M
-4.47M
-5.43M
-4.57M
Income tax expense
549.29K
70.12K
183.07K
104.07K
Effective tax rate
-11.60%
-1.57%
-3.37%
-2.28%
Other operating expenses
-
-
-
-
Net income
-5.28M
-4.54M
-5.61M
-4.68M
Net profit margin
-
-
-
-
Earnings per share
-0.15
-0.11
-0.13
-0.11
Interest and investment income
83.30K
88.58K
93.34K
60.73K
Interest expense
-
-
-
-
Net interest expenses
83.30K
88.58K
93.34K
60.73K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.78M
-4.46M
-5.34M
-4.67M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps